[1]沈雨,吴苗琴.Th1、Th2和Th17型细胞因子水平与糖尿病视网膜病变的相关性研究进展[J].眼科新进展,2020,40(2):192-196.[doi:10.13389/j.cnki.rao.2020.0046]
　SHEN Yu,WU Miaoqin.Resent advances in the correlation between Th1,Th2,Th17 cytokine levels and diabetic retinopathy[J].Recent Advances in Ophthalmology,2020,40(2):192-196.[doi:10.13389/j.cnki.rao.2020.0046]
点击复制

Th1、Th2和Th17型细胞因子水平与糖尿病视网膜病变的相关性研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年2期
页码:
192-196
栏目:
文献综述
出版日期:
2020-02-05

文章信息/Info

Title:
Resent advances in the correlation between Th1,Th2,Th17 cytokine levels and diabetic retinopathy
作者:
沈雨; 吴苗琴
310053　浙江省杭州市，浙江中医药大学第二临床医学院（沈雨）；310014　浙江省杭州市，浙江省人民医院眼科(吴苗琴)
Author(s):
SHEN Yu1; WU Miaoqin2
1.The Second Clinical Medicine Faculty，Zhejiang Chinese Medical University，Hangzhou 310053，Zhejiang Province，China
2.Zhejiang Provincial People’s Hospital，Hangzhou 310014，Zhejiang Province，China
关键词:
糖尿病视网膜病变; Th1; Th2; Th17; 细胞因子
Keywords:
diabetic retinopathy; Th1; Th2; Th17; cytokines
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2020.0046
文献标志码:
A
摘要:
糖尿病视网膜病变(diabetic retinopathy，DR)是目前主要的致盲眼病，其发病机制复杂且尚未明确，近年发现免疫炎症反应和细胞因子在其发病中起重要作用。Th1、Th2、Th17型细胞因子在DR中分泌异常，作用并影响了疾病的发生发展。本文就Th1、Th2、Th17型细胞因子与DR的相关性研究进展作一综述。
Abstract:
Diabetic retinopathy (DR) is currently the main cause of blindness.Its pathogenesis is complex and unclear.In recent years,it has been found that immune inflammation and cytokines play an important role in the pathogenesis of DR.Th1,Th2,Th17 cytokines are abnormally secreted in diabetic retinopathy,which affects the occurrence and development of the disease.This article reviews recent progress in the study of correlation between Th1,Th2,Th17 cytokines and DR.

参考文献/References:

［1］　GUCCIARDO E，LOUKOVAARA S，SALVEN P，LEHTI K.Lymphatic vascular structures:a new aspect in proliferative diabetic retinopathy［J］.Int J Mol Sci，2018，19(12):4034.
［2］　BOYNTON G E，STEM M S，KWARK L，JACKSON G R，FARSIU S，GARDNER T W.Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure［J］.Ophthalmology，2015，122(5):957-967.
［3］　AHSAN H.Diabetic retinopathy - Biomolecules and multiple pathophysiology［J］.Diabetes Metab Syndr，2015，9(1):51-54.
［4］　XIE M，HU A，LUO Y，SUN W，HU X，TANG S.Interleukin-4 and melatonin ameliorate high glucose and interleukin-1β stimulated inflammatory reaction in human retinal endothelial cells and retinal pigment epithelial cells［J］.Mol Vis，2014，20(6):921-928.
［5］　TSAI T，KUEHN S，TSIAMPALIS N，VU M-K，KAKKASSERY V，STUTE G，et al.Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients［J］.PLoS One，2018，13(3):e0194603.
［6］　SIM R，HERNNDEZ C.Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence［J］.Prog Retin Eye Res，2015，48:160-180.
［7］　STITT A W，CURTIS T M，CHEN M，MEDINA R J，MCKAY G J，JENKINS A，et al.The progress in understanding and treatment of diabetic retinopathy［J］.Prog Retin Eye Res，2016，51:156-186.
［8］　TOLENTINO M S，TOLENTINO A J，TOLENTINO M J.Current and investigational drugs for the treatment of diabetic retinopathy［J］.Expert Opin Investig Drugs，2016，25(9):1011-1022.
［9］　YU Y，CHEN H，SU S B.Neuroinflammatory responses in diabetic retinopathy［J］.J Neuroinflammation，2015，12(1):141.
［10］　GENG Y，YU Y，LIU T，LU L，LI D，YU H，et al.Levels of inflammatory cytokines IL-1β，IL-6，IL-8，IL-17A，and TNF-α in aqueous humour of patients with diabetic retinopathy［J］.J Diabetes Res，2018，2018(1):1-6.
［11］　KAUL K，HODGKINSON A M，TARR J M，KOHNER E，CHIBBER R.Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?［J］.Curr Diabetes Rev，2010，6(5):294-303.
［12］　AL-KHARASHI A S.Role of oxidative stress，inflammation，hypoxia and angiogenesis in the development of diabetic retinopathy［J］.Saudi J Ophthalmol，2018，32(4):318-323.
［13］　GARCIA F A，REBOUAS J F，BALBINO T Q，SILVA T G，CARVALHO-JNIOR C H，CERQUEIRA G S，et al.Pentoxifylline reduces the inflammatory process in diabetic rats:relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase［J］.J Inflamm，2015，12(1):33.
［14］　CAO Y L，ZHANG F Q，HAO F Q.Th1/Th2 cytokine expression in diabetic retinopathy［J］.Genet Mol Res，2016，15(3):gmr.15037311.
［15］　VARGAS-ROJAS M I，SOLLEIRO-VILLAVICENCIO H，SOTO-VEGA E.Th1，Th2，Th17 and Treg levels in umbilical cord blood in preeclampsia［J］.J Matern Fetal Neonatal Med，2016，29(10):1-14.
［16］　KORN T，BETTELLI E，OUKKA M，KUCHROO V K.IL-17 and TH17 cells［J］.Annu Rev Immunol，2009，27(1):485-517.
［17］　KONG F，ZHANG W，FENG B，ZHANG H，RAO H，WANG J，et al.Abnormal CD4+T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection［J］.Virol J，2015，12(1):100.
［18］　NAHOMI R B，SAMPATHKUMAR S，MYERS A M，ELGHAZI L，SMITH D G，TANG J，et al.The absence of indoleamine 2，3-Dioxygenase inhibits retinal capillary degeneration in diabetic mice［J］.Invest Ophthalmol Vis Sci，2018，59(5):2042-2053.
［19］　JOHNSEN-SORIANO S，SANCHO-TELLO M，ARNAL E，NAVEA A，CERVERA E，BOSCH-MORELL F，et al.IL-2 and IFN-gamma in the retina of diabetic rats［J］.Graefes Arch Clin Exp Ophthalmol，2010，248(7):985-990.
［20］　HUANG H，GANDHI J K，ZHONG X，WEI Y，GONG J，DUH E J，et al.TNF is required for late BRB breakdown in diabetic retinopathy，and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis［J］.Invest Ophthalmol Vis Sci，2011，52(3):1336-1344.
［21］　JOUSSEN A M，DOEHMEN S，LE M L，KOIZUMI K，RADETZKY S，KROHNE T U，et al.TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations［J］.Mol Vis，2009，15(151):1418-1428.
［22］　LI H，ZHANG J，LIN L，XU L.Vascular protection of DPP-4 inhibitors in retinal endothelial cells in in vitro culture［J］.Int Immunopharmacol，2019，66:162-168.
［23］　KOLEVAGEORGIEVA D N，SIVKOVA N P，TERZIEVA D.Serum inflammatory cytokines IL-1beta，IL-6，TNF-alpha and VEGF have influence on the development of diabetic retinopathy［J］.Folia Med，2011，53(2):44-50.
［24］　DEMIRCAN N，SAFRAN B G，SOYLU M，OZCAN A A，SIZMAZ S.Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy［J］.Eye，2006，20(12):1366-1369.
［25］　SFIKAKIS P P，MARKOMICHELAKIS N，THEODOSSIADIS G P，GRIGOROPOULOS V，KATSILAMBROS N，THEODOSSIADIS P G.Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab［J］.Diabetes Care，2005，28(2)：445-447.
［26］　HKANSSON K，BACHERT C，KONGE L，THOMSEN S F，PEDERSEN A E，POULSEN S S，et al.Airway inflammation in chronic rhinosinusitis with nasal polyps and asthma:the united airways concept further supported［J］.PLoS One，2015，10(7):e0127228.
［27］　HANG H，YUAN S，YANG Q，YUAN D，LIU Q.Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy［J］.Mol Vis，2014，20(4):1137-1145.
［28］　WU H，HWANG D K，SONG X，TAO Y.Association between aqueous cytokines and diabetic retinopathy stage［J］.J Ophthalmol，2017，2017:1-8.
［29］　CHEN H，ZHANG X，LIAO N，WEN F.Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy［J］.BMC Ophthalmol，2017，17(1):176.
［30］　PETROVI C ˇ M G，KOROEC P，KONIK M，HAWLINA M.Association of preoperative vitreous IL-8 and VEGF levels with visual acuity after vitrectomy in proliferative diabetic retinopathy［J］.Acta Ophthalmol，2010，88(8):e311-e316.
［31］　RACZYSKA D，LISOWSKA K A，PIETRUCZUK K，BORUCKA J， S ′ LIZIE M，RACZYSKA K，et al.The level of cytokines in the vitreous body of severe proliferative diabetic retinopathy patients undergoing posterior vitrectomy［J］.Curr Pharm Des，2018，24(27):3276-3281.
［32］　HAOSHEN S，BERGER E A.Characterization of site-specific phosphorylation of NF-κB p65 in retinal cells in response to high glucose and cytokine polarization［J］.Mediators Inflamm，2018，2018:3020675.
［33］　TAKEUCHI M，SATO T，TANAKA A，MURAOKA T，TAGUCHI M，SAKURAI Y，et al.Elevated levels of cytokines associated with Th2 and Th17 cells in vitreous fluid of proliferative diabetic retinopathy patients［J］.PLoS One，2015，10(9):e0137358.
［34］　SUN J，LIU C.Correlation of vascular endothelial function and coagulation factors with renal function and inflammatory factors in patients with diabetic nephropathy［J］.Exp Ther Med，2018，16(5):4167-4171.
［35］　MA Y，TAO Y，LU Q，JIANG Y R.Intraocular expression of serum amyloid a and interleukin-6 in proliferative diabetic retinopathy［J］.Am J Ophthalmol，2011，152(4):678-685.
［36］　GUSTAVSSON C，AGARDH C D，AGARDH E.Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy［J］.Acta Ophthalmol，2013，91(5):445-452.
［37］　ADAMIEC-MROCZEK J，OFICJALSKA-MYCZAK J，MISIUK-HOJO M.Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy:Analysis of vitreous samples［J］.Cytokine，2010，49(3):269-274.
［38］　FUNATSU H，YAMASHITA H，NOMA H，MIMURA T，NAKAMURA S，SAKATA K，et al.Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients［J］.Graefes Arch Clin Exp Ophthalmol，2005，243(1):3-8.
［39］　YAO Y，LI R，DU J，LONG L，LI X，LUO N.Interleukin-6 and Diabetic Retinopathy:A systematic review and meta-analysis［J］.Curr Eye Res，2019:44(5):564-574.
［40］　YU Y，ZHANG J，ZHU R，ZHAO R，CHEN J，JIN J，et al.The profile of angiogenic factors in vitreous humor of the patients with proliferative diabetic retinopathy［J］.Curr Mol Med，2017，17(4):280-286.
［41］　SEN A，PAINE S K，CHOWDHURY I H，MUKHERJEE A，CHOUDHURI S，SAHA A，et al.Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales’ disease［J］.Mol Vis，2011，17:2552-2563.
［42］　MY S ′ LIWIEC M，ZORENA K，BALCERSKA A，MY S ′ LIWSKA J，LIPOWSKI P，RACZYSKA K.The activity of -acetyl-beta--glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children［J］.Clin Biochem，2006，39(8):851-856.
［43］　HERNNDEZ C，SEGURA R M，FONOLLOSA A，CARRASCO E，FRANCISCO G，SIM R.Interleukin-8，monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy［J］.Diabet Med，2010，22(6):719-722.
［44］　BROMBERG-WHITE J L，GLAZER L，DOWNER R，FURGE K，BOGUSLAWSKI E，DUESBERY N S.Identification of VEGF-Independent cytokines in proliferative diabetic retinopathy vitreous［J］.Invest Ophthalmol Vis Sci，2013，54(10):6472-6480.
［45］　DONG N，XU B，CHU L，TANG X.Study of 27 aqueous humor cytokines in type 2 diabetic patients with or without macular edema［J］.PLoS One，2015，10(4):e0125329.
［46］　TAKEUCHI M，SATO T，SAKURAI Y，TAGUCHI M，HARIMOTO K，KARASAWA Y，et al.Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy［J］.PLoS One，2017，12(5):e0178230.
［47］　HIROTA K，AHLFORS H，DUARTE J H，STOCKINGER B.Regulation and function of innate and adaptive interleukin-17-producing cells［J］.EMBO Rep，2012，13(2):113-120.
［48］　LIU S，LIN Y，LIU X.Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression［J］.Exp Ther Med，2015，11(1):257-263.
［49］　CHEN H，REN X，LIAO N，WEN F.Th17 cell frequency and IL-17A concentrations in peripheral blood mononuclear cells and vitreous fluid from patients with diabetic retinopathy［J］.Int Med Res，2016，44(6):1403-1413.
［50］　CHERNYKH V V，VARVARINSKY E V，SMIRNOV E V，CHERN-YKH D V，TRUNOV A N.Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy［J］.Indian J Ophthalmol，2015，63(1):33-36.
［51］　QIU A W，LIU Q H，WANG J L.Blocking IL-17A alleviates diabetic retinopathy in rodents［J］.Cell Physiol Biochem，2017，41(3):960-972.
［52］　JIANG H，KUANG H Y.Inflammatory cytokines and diabetic retinopathy［J］.Int J Endocrinal Metab，2007，27:31-33.
［53］　HAN J，LI Y，LIU X，ZHOU T，SUN H，EDWARDS P，et al.Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo［J］.PLoS One，2018，13(3):e0193031.
［54］　CHEN X，HAN R，HAO P，WANG L，LIU M，JIN M，et al.Nepetin inhibits IL-1β induced inflammation via NF-κB and MAPKs signaling pathways in ARPE-19 cells［J］.Biomed Pharmacother，2018，101:87-93.
［55］　BOGDANOV P，SOL-ADELL C，HERNNDEZ C，GARCA-RAMREZ M，SAMPEDRO J，SIM-SERVAT O，et al.Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice［J］.J Diabetes Complicat，2017，31(10):1481-1490.
［56］　JU H B，ZHANG F X，WANG S，SONG J，CUI T，LI L F，et al.Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients［J］.Medicine，2017，96(31):e7671.
［57］　YI X，SUN J，LI L，WEI Q，QIAN Y，CHEN X，et al.1，25-Dihydroxyvitamin D3 deficiency is involved in the pathogenesis of diabetic retinopathy in the uygur population of China［J］.IUBMB Life，2016，68(6):445-451.
［58］　LEI X，HE J，REN C，ZHOU Y，CHEN X，DOU J.Protective effects of the Chinese herbal medicine prescription Zhujing pill on retina of streptozotocin-induced diabetic rats［J］.Biomed Pharmacother，2018，98:643-650.
［59］　LEI X，ZHOU Y，REN C，CHEN X，SHANG R，HE J，et al.Typhae pollen polysaccharides ameliorate diabetic retinal injury in a streptozotocin-induced diabetic rat model［J］.J Ethnopharmacol，2018，224:169-176.
［60］　DONGARE S，GUPTA S K，MATHUR R，SAXENA R，MATHUR S，AGARWAL R，et al.Zingiber officinale attenuates retinal microvascular changes in diabetic rats via anti-inflammatory and antiangiogenic mechanisms［J］.Mol Vis，2016，22:599-609.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.

备注/Memo

备注/Memo:
浙江省科技厅重大专项（编号：2014C03042-1）；浙江省医药卫生科技计划项目（编号：WKJ-ZJ-1817）
更新日期/Last Update: 2020-02-05